If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
882.00    22.00 (2.56%)
Bid:
870.00
Ask:
892.00
Spread: 22.00 (2.529%)
Market Cap: £241.41m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Half Year Trading Update

6 Apr 2018 07:00

RNS Number : 0313K
Gooch & Housego PLC
06 April 2018
 

FOR IMMEDIATE RELEASE

6 April 2018

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Half Year Trading Update

 

"Full year trading remains in line with management's expectations"

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, announces that trading in the six months to 31 March 2018 was in line with management's expectations.

Management expects full year trading to be in line with its expectations, with a typical higher second half weighting.

In our 21 February 2018 AGM trading update we reported that the Company has benefited from positive overall market conditions. This remains the case and there continue to be exceptional levels of demand for critical components used in microelectronic manufacturing. As previously reported, the demand for high reliability fibre couplers has been at a lower level since the start of the year, but we continue to expect demand to come back in the second half of the year.

Our order book is at a record level for the half year. As at 31 March 2018, it stood at £84.7million, an increase of 27.1% compared with the same time last year. Excluding the impact of foreign exchange this represents an increase of 36.4%.

As previously reported, G&H's manufacturing sites have been reorganised into three technical groups, namely Acousto Optic/ Electro Optic, Precision Optic and Fibre Optic. This is part of becoming a more scalable organisation able to accommodate the anticipated growth rates. There have already been benefits, as we upgrade capacity and performance at those sites manufacturing critical parts for the microelectronic sector.

The Company's Interim Results, for the six months ended 31 March 2018, are expected to be announced on Tuesday 5 June 2018.

Mark Webster, Chief Executive Officer of Gooch & Housego, commented:

"Overall market conditions remain good. We have a record half year order book and full year trading is expected to be in line with management's expectations.

"The introduction of a new manufacturing organisation has enabled us to more readily upgrade capacity and performance, in particular at our Ilminster and Fremont, CA sites, in order to meet the unprecedented levels of demand in the microelectronic sector.

"G&H remains committed to our strategy of diversification and moving up the value chain. We have an active policy of building a diverse and balanced business by establishing a 'critical mass' in A&D and life sciences, through investing in a mix of R&D and acquisitions. A&D now represents about a third of our business."

 

For further information contact:

 

Mark Webster / Andrew Boteler

Gooch & Housego PLC

01460 256440

Mark Court / Sophie Wills

Buchanan

020 7466 5000

Patrick Robb / David Anderson

Investec Bank plc

020 7597 5970

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSAFMIFASEFL
Date   Source Headline
9th Mar 20097:00 amRNSMarket Update
29th Jan 20094:04 pmRNSTrading Update
1st Dec 200810:56 amRNSDirector Share Dealing
25th Nov 200812:27 pmRNSPreliminary Results - Replacement
25th Nov 20087:00 amRNSPreliminary Results
5th Nov 20087:00 amRNSNotice of Results
10th Oct 20087:00 amRNSAcquisition of General Optics
9th Oct 20087:00 amRNSFull Year Trading Update
25th Sep 200811:47 amRNSInvestor and Analyst Site Visits
19th Sep 20083:11 pmRNSShare Option Purchase
4th Jul 20087:00 amRNSAcquisition of General Optics
24th Jun 20087:00 amRNSChange of NOMAD & Broker
17th Jun 20087:00 amRNSInterim Results
27th May 20087:00 amRNSIFRS
13th May 20086:00 amRNSNotice of Results
9th Apr 20087:00 amRNSTrading Update
28th Mar 20089:59 amRNSAnnual Report and Accounts
12th Mar 20084:37 pmRNSAdditional Listing
13th Feb 200811:00 amRNSAGM Statement
5th Feb 20087:01 amRNSVendor Appreciation Award
22nd Jan 20087:01 amRNSGlobal Integration
7th Jan 20088:53 amRNSAdditional Listing
7th Jan 20087:01 amRNSSIFAM Order
4th Jan 200812:32 pmRNSDirector Shareholding
21st Dec 20074:46 pmRNSHolding(s) in Company
21st Dec 20074:35 pmRNSAdditional Listing
7th Dec 20073:00 pmRNSLong Term Incentive Plan
3rd Dec 200712:20 pmRNSAdditional Listing
30th Nov 20073:44 pmRNSHolding(s) in Company
27th Nov 20077:00 amRNSAppointment
27th Nov 20077:00 amRNSPreliminary Results
15th Nov 20077:01 amRNSAppointment
29th Oct 20077:01 amRNSNotice of Results
4th Oct 20077:01 amRNSFull Year Trading Update
23rd Aug 20078:26 amRNSAdditional Listing
22nd Aug 20075:38 pmRNSDirector Shareholdings
17th Aug 20076:23 pmRNSAIM Rule 26
16th Aug 20072:12 pmRNSAdditional Listing
14th Aug 200712:36 pmRNSLTIP Awards
10th Aug 20075:18 pmRNSDirector Shareholdings
17th Jul 20074:16 pmRNSDirector of Sales Appointment
5th Jun 20077:02 amRNSInterim Results
31st May 20079:55 amRNSTotal Voting Rights
10th May 20079:58 amRNSHolding(s) in Company
9th May 20077:01 amRNSNotice of Results
8th May 20071:53 pmRNSAdditional Listing
8th May 20077:02 amRNSAcquisition
11th Apr 20077:01 amRNSTrading Update
8th Mar 20075:54 pmRNSHolding(s) in Company
14th Feb 20077:01 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.